Patel Sanj K exercised Options covering 31,318 Kiniksa shares on Sep 1, 2026, and received awards for 150,200 derivative securities at $0 per share. For investors, the transactions set out his post-transaction holdings of 92,348 shares and zero derivative securities across the reported categories.
Key Highlights
- Patel Sanj K forfeited 15,144 Kiniksa shares at $79.28 per share.
- Two transactions awarded him 150,200 derivative securities at $0 per share.
- His reported derivative-security holdings fell to zero after option exercises.
Patel Sanj K, chairman and CEO of Kiniksa Pharmaceuticals International, plc, exercised options covering 31,318 shares on Sep 1, 2026. His reported share ownership after those transactions was 107,492 shares. The same date also covered a share forfeiture, derivative-security awards and additional option exercises.
Kiniksa Insider Transactions Span Shares and Derivatives
Patel Sanj K forfeited 15,144 shares at $79.28 per share under a transaction coded F, leaving reported ownership of 92,348 shares. Two transactions coded A awarded him a combined 150,200 derivative securities at $0 per share. His derivative-security holdings after those awards were reported at 120,150. Separate transactions coded M covered option exercises involving 31,318 derivative securities at $0 per share. Reported derivative ownership after those exercises was zero. The transactions were dated 1 September 2026.
FAQs
Q: What did Patel Sanj K report in the Kiniksa insider transaction?
A: Patel Sanj K exercised options covering 31,318 Kiniksa shares and reported 107,492 shares afterward. He also reported derivative-security awards and exercises dated 1 September 2026.
Q: How did Patel Sanj K’s Kiniksa holdings change?
A: Patel Sanj K’s reported share ownership stood at 92,348 shares after a 15,144-share forfeiture priced at $79.28 per share. His derivative holdings were later reported at zero.
Q: What derivative securities did Patel Sanj K receive?
A: Patel Sanj K received awards for 150,200 derivative securities at $0 per share across two transactions. His reported derivative holdings after those awards were 120,150.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.